Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDpoetin versus Cinapoietin for anemia in children with chronic renal failure
IRCT20180222038824N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2018
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darbepoetin alfa in Uraemic Anaemia (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Improvement in hemoglobin concentration. Started Feb 2018; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on IRCT20180222038824N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180222038824N1.